Y. Wang, et.al., SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability., Oncogene, 2010, 29

http://rdf.ncbi.nlm.nih.gov/pubmed/20348955

Y. Wang, et.al., SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability., Oncogene, 2010, 29

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD13011
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD13011

allele

http://purl.org/net/cito/citesAsAuthority

• Ssbp2<tm1Lana>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4462848

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased malignant tumor incidence_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0002018I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• increased B cell derived lymphoma incidence_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0002023I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• premature death_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0002083I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• increased lung adenoma incidence_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0002048I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• increased carcinoma incidence_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0002038I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• increased pre-B cell number_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0003132I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• abnormal joint morphology_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0002932I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• increased T cell derived lymphoma incidence_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>,Trp53<tm1Tyj>/Trp53<tm1Tyj>
  http://metadb.riken.jp/0002024I129SSvEv129S2SvPasBALBcC57BL6Ssbp2tm1LanaSsbp2tm1LanaTrp53tm1TyjTrp53tm1TyjSsbp2tm1LanaTrp53tm1Tyj
• increased adenoma incidence_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0010383I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• increased sarcoma incidence_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0002032I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• decreased lymphocyte cell number_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0005016I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• pancytopenia_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0005152I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• thymus hypoplasia_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>,Trp53<tm1Tyj>/Trp53<tm1Tyj>
  http://metadb.riken.jp/0001823I129SSvEv129S2SvPasBALBcC57BL6Ssbp2tm1LanaSsbp2tm1LanaTrp53tm1TyjTrp53tm1TyjSsbp2tm1LanaTrp53tm1Tyj
• increased jejunum adenocarcinoma incidence_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0009312I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• arteritis_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0010138I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• increased squamous cell carcinoma incidence_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0004207I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• abnormal kidney morphology_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0002135I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• increased lymphoma incidence_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0012431I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• perinatal lethality, incomplete penetrance_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0011090I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana
• premature death_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>,Trp53<tm1Tyj>/Trp53<tm1Tyj>
  http://metadb.riken.jp/0002083I129SSvEv129S2SvPasBALBcC57BL6Ssbp2tm1LanaSsbp2tm1LanaTrp53tm1TyjTrp53tm1TyjSsbp2tm1LanaTrp53tm1Tyj
• anemia_Ssbp2<tm1Lana>/Ssbp2<tm1Lana>
  http://metadb.riken.jp/0001577I129SSvEvC57BL6Ssbp2tm1LanaSsbp2tm1LanaSsbp2tm1Lana